| A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction G Pelicci, L Lanfrancone, F Grignani, J McGlade, F Cavallo, G Forni, ... Cell 70 (1), 93-104, 1992 | 1699 | 1992 |
| Classification of current anticancer immunotherapies L Galluzzi, E Vacchelli, JM Bravo-San Pedro, A Buqué, L Senovilla, ... Oncotarget 5 (24), 12472, 2014 | 547 | 2014 |
| Vaccines for tumour prevention PL Lollini, F Cavallo, P Nanni, G Forni Nature Reviews Cancer 6 (3), 204-216, 2006 | 398 | 2006 |
| Psychometric validation of the revised family affluence scale: a latent variable approach T Torsheim, F Cavallo, KA Levin, C Schnohr, J Mazur, B Niclasen, ... Child indicators research 9, 771-784, 2016 | 385 | 2016 |
| Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice K Boggio, G Nicoletti, E Di Carlo, F Cavallo, L Landuzzi, C Melani, ... The Journal of experimental medicine 188 (3), 589-596, 1998 | 373 | 1998 |
| 2011: the immune hallmarks of cancer F Cavallo, C De Giovanni, P Nanni, G Forni, PL Lollini Cancer Immunology, Immunotherapy 60, 319-326, 2011 | 360 | 2011 |
| Zoledronic acid repolarizes tumour‐associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway M Coscia, E Quaglino, M Iezzi, C Curcio, F Pantaleoni, C Riganti, I Holen, ... Journal of cellular and molecular medicine 14 (12), 2803-2815, 2010 | 317 | 2010 |
| Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice P Nanni, G Nicoletti, C De Giovanni, L Landuzzi, E Di Carlo, F Cavallo, ... The Journal of experimental medicine 194 (9), 1195-1206, 2001 | 291 | 2001 |
| Subjective health, symptom load and quality of life of children and adolescents in Europe U Ravens-Sieberer, T Torsheim, J Hetland, W Vollebergh, F Cavallo, ... International journal of public health 54, 151-159, 2009 | 271 | 2009 |
| Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene. F Cavallo, M Giovarelli, A Gulino, A Vacca, A Stoppacciaro, A Modesti, ... Journal of immunology (Baltimore, Md.: 1950) 149 (11), 3627-3635, 1992 | 246 | 1992 |
| Girls growing through adolescence have a higher risk of poor health F Cavallo, A Zambon, A Borraccino, U Raven-Sieberer, T Torsheim, ... Quality of life Research 15, 1577-1585, 2006 | 227 | 2006 |
| Cytokines, tumour-cell death and immunogenicity: a question of choice P Musiani, A Modesti, M Giovarelli, F Cavallo, G Forni, PL Lollini, ... Immunology today 18 (1), 32-36, 1997 | 219 | 1997 |
| Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor … A Allione, M Consalvo, P Nanni, PL Lollini, F Cavallo, M Giovarelli, ... Cancer research 54 (23), 6022-6026, 1994 | 218 | 1994 |
| Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and … M Giovarelli, P Musiani, A Modesti, P Dellabona, G Casorati, A Allione, ... Journal of immunology (Baltimore, Md.: 1950) 155 (6), 3112-3123, 1995 | 213 | 1995 |
| Reduction of crying episodes owing to infantile colic: a randomized controlled study on the efficacy of a new infant formula F Savino, E Palumeri, E Castagno, F Cresi, P Dalmasso, F Cavallo, ... European journal of clinical nutrition 60 (11), 1304-1310, 2006 | 203 | 2006 |
| Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice E Quaglino, M Iezzi, C Mastini, A Amici, F Pericle, E Di Carlo, SM Pupa, ... Cancer research 64 (8), 2858-2864, 2004 | 199 | 2004 |
| Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12 F Cavallo, M Giovarelli, G Forni, P Signorelli, P Musiani, A Modesti, ... Journal of the National Cancer Institute 89 (14), 1049-1058, 1997 | 197 | 1997 |
| IL-12 inhibition of endothelial cell functions and angiogenesis depends on lymphocyte-endothelial cell cross-talk M Strasly, F Cavallo, M Geuna, S Mitola, MP Colombo, G Forni, ... The Journal of Immunology 166 (6), 3890-3899, 2001 | 193 | 2001 |
| Immune events associated with the cure of established tumors and spontaneous metastases by local and systemic interleukin 12 F Cavallo, ED Carlo, M Butera, R Verrua, MP Colombo, P Musiani, ... Cancer research 59 (2), 414-421, 1999 | 182 | 1999 |
| Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of Cten I Barbieri, S Pensa, T Pannellini, E Quaglino, D Maritano, M Demaria, ... Cancer research 70 (6), 2558-2567, 2010 | 171 | 2010 |
Pier-Luigi LolliniProfessor of Molecular Oncology, University of Bologna, ItalyVerified email at unibo.it
